Thomas Kluz, Managing Director at Niterra Ventures
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked…
Continue Reading
Background: Assessing fall risk, especially in individuals with neurological disorders, is essential to prevent hospitalization, hypomobility, and reduced functional independence. Wearable sensors are increasingly used in neurorehabilitation, as they enable unsupervised fall risk assessment…
Continue Reading
What You Should Know:
– Ambience Healthcare, Caregility, Five9, Imprivata and NESA announced they have recently been added to or are in the process of being integrated into Epic’s Toolbox, signaling a new wave of…
Continue Reading
Bilal Naved, Ph, co-founder & Chief Product Officer at Clearstep
U.S. health systems are navigating a storm of staff shortages, budget constraints, and rising patient demand. But there’s another, less visible factor compounding these pressures:…
Continue Reading
What You Should Know:
– Teladoc Health announced the acquisition of Telecare, an innovative Australian technology-enabled company specializing in virtual delivery of specialist and allied healthcare. Financial details of the acquisition were not disclosed.
– Under…
Continue Reading
What You Should Know:
– San Francisco-based Citizen Health, a platform empowering patients with rare and complex conditions, secures $30M in Series A funding led by 8VC, with participation from Transformation Capital and Headline, bringing…
Continue Reading
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading
What You Should Know:
– Ahead of the upcoming Epic Annual Users Group Meeting (UGM), NESA, Imprivata, and Five9 have recently been added to or are in the process of being integrated into Epic’s Toolbox,…
Continue Reading
Background: Today, virtually all smartphones provide a digital voice assistant (DVA) for their user, and it is estimated that about 91% of adults report owning and operating a smartphone. A DVA is an automated…
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
